Skip to main content

Institutional filer profile

OrbiMed Capital GP IX LLC Insider Trades

Latest reported as Corporate insider of Braveheart Bio, Inc. (BRVE).

Purchase filings
1
Reported companies
1
Net open-market value
$34,920,000
Latest transaction
Aug 7, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 7, 2026Braveheart Bio, Inc. (BRVE)Corporate insiderOpen Market Purchase1,940,000$18.00$34,920,000